Brandes Investment Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $256M | Buy |
9,107,225
+478,043
| +6% | +$12.7M | 1.81% | 11 |
|
|
2025
Q4 | $215M | Buy |
8,629,182
+216,411
| +3% | +$5.46M | 1.64% | 15 |
|
|
2025
Q3 | $214M | Buy |
8,412,771
+370,062
| +5% | +$9.13M | 1.72% | 15 |
|
|
2025
Q2 | $195M | Buy |
8,042,709
+992,637
| +14% | +$23.1M | 1.76% | 15 |
|
|
2025
Q1 | $179M | Buy |
7,050,072
+341,908
| +5% | +$8.95M | 1.82% | 15 |
|
|
2024
Q4 | $178M | Buy |
6,708,164
+962,837
| +17% | +$26.1M | 1.99% | 10 |
|
|
2024
Q3 | $166M | Buy |
5,745,327
+172,045
| +3% | +$5.02M | 1.87% | 15 |
|
|
2024
Q2 | $156M | Buy |
5,573,282
+516,714
| +10% | +$14.2M | 1.92% | 14 |
|
|
2024
Q1 | $140M | Buy |
5,056,568
+721,719
| +17% | +$20M | 1.81% | 15 |
|
|
2023
Q4 | $125M | Buy |
4,334,849
+1,377,426
| +47% | +$41.6M | 1.89% | 13 |
|
|
2023
Q3 | $98.1M | Buy |
2,957,423
+119,009
| +4% | +$4.21M | 1.92% | 17 |
|
|
2023
Q2 | $104M | Buy |
2,838,414
+426,855
| +18% | +$16.6M | 2.1% | 14 |
|
|
2023
Q1 | $98.4M | Buy |
2,411,559
+431,989
| +22% | +$18.7M | 2.09% | 14 |
|
|
2022
Q4 | $101M | Sell |
1,979,570
-321,654
| -14% | -$15.4M | 2.84% | 7 |
|
|
2022
Q3 | $101M | Buy |
2,301,224
+29,829
| +1% | +$1.45M | 2.63% | 6 |
|
|
2022
Q2 | $119M | Buy |
2,271,395
+1,191
| +0.1% | +$60.7K | 2.91% | 6 |
|
|
2022
Q1 | $118M | Buy |
2,270,204
+98,982
| +5% | +$5.14M | 2.52% | 8 |
|
|
2021
Q4 | $128M | Sell |
2,171,222
-232,982
| -10% | -$11.5M | 2.8% | 4 |
|
|
2021
Q3 | $103M | Buy |
2,404,204
+60,616
| +3% | +$2.69M | 2.24% | 8 |
|
|
2021
Q2 | $91.8M | Buy |
2,343,588
+480,678
| +26% | +$18.7M | 2.04% | 8 |
|
|
2021
Q1 | $67.3M | Buy |
1,862,910
+73,613
| +4% | +$2.61M | 1.59% | 16 |
|
|
2020
Q4 | $65.7M | Sell |
1,789,297
-113,286
| -6% | -$4.16M | 1.69% | 13 |
|
|
2020
Q3 | $66.2M | Sell |
1,902,583
-241,252
| -11% | -$8.46M | 2.29% | 8 |
|
|
2020
Q2 | $66.5M | Sell |
2,143,835
-268,205
| -11% | -$9.11M | 2.02% | 12 |
|
|
2020
Q1 | $74.7M | Sell |
2,412,040
-31,315
| -1% | -$1.07M | 2.61% | 6 |
|
|
2019
Q4 | $90.8M | Sell |
2,443,355
-76,824
| -3% | -$2.74M | 2.16% | 10 |
|
|
2019
Q3 | $85.9M | Sell |
2,520,179
-122,146
| -5% | -$4.44M | 2.22% | 10 |
|
|
2019
Q2 | $109M | Sell |
2,642,325
-146,242
| -5% | -$5.81M | 2.42% | 8 |
|
|
2019
Q1 | $112M | Sell |
2,788,567
-418,356
| -13% | -$16.8M | 2.61% | 7 |
|
|
2018
Q4 | $133M | Sell |
3,206,923
-313,440
| -9% | -$13M | 3.38% | 3 |
|
|
2018
Q3 | $147M | Sell |
3,520,363
-87,544
| -2% | -$3.37M | 3.32% | 4 |
|
|
2018
Q2 | $124M | Sell |
3,607,907
-82,831
| -2% | -$2.83M | 2.8% | 4 |
|
|
2018
Q1 | $124M | Sell |
3,690,738
-216,734
| -6% | -$7.45M | 2.65% | 5 |
|
|
2017
Q4 | $134M | Sell |
3,907,472
-120,565
| -3% | -$4.11M | 2.71% | 4 |
|
|
2017
Q3 | $136M | Sell |
4,028,037
-1,383,947
| -26% | -$44.5M | 2.77% | 4 |
|
|
2017
Q2 | $172M | Sell |
5,411,984
-930,993
| -15% | -$29.4M | 2.73% | 5 |
|
|
2017
Q1 | $206M | Buy |
6,342,977
+786,902
| +14% | +$24.8M | 3.06% | 4 |
|
|
2016
Q4 | $171M | Buy |
5,556,075
+252,340
| +5% | +$7.7M | 2.57% | 9 |
|
|
2016
Q3 | $170M | Sell |
5,303,735
-209,840
| -4% | -$7.02M | 2.56% | 9 |
|
|
2016
Q2 | $184M | Sell |
5,513,575
-321,712
| -6% | -$10.3M | 2.81% | 5 |
|
|
2016
Q1 | $164M | Sell |
5,835,287
-108,785
| -2% | -$3.11M | 2.35% | 9 |
|
|
2015
Q4 | $182M | Sell |
5,944,072
-236,269
| -4% | -$7.43M | 2.66% | 7 |
|
|
2015
Q3 | $184M | Sell |
6,180,341
-201,506
| -3% | -$6.46M | 2.69% | 7 |
|
|
2015
Q2 | $203M | Sell |
6,381,847
-72,360
| -1% | -$2.36M | 2.6% | 5 |
|
|
2015
Q1 | $213M | Sell |
6,454,207
-156,583
| -2% | -$4.98M | 2.93% | 5 |
|
|
2014
Q4 | $195M | Buy |
6,610,790
+15,817
| +0.2% | +$454K | 2.76% | 6 |
|
|
2014
Q3 | $185M | Buy |
6,594,973
+191,438
| +3% | +$5.37M | 2.45% | 10 |
|
|
2014
Q2 | $180M | Buy |
6,403,535
+349,664
| +6% | +$9.97M | 2.18% | 15 |
|
|
2014
Q1 | $184M | Sell |
6,053,871
-24,971
| -0.4% | -$745K | 2.33% | 12 |
|
|
2013
Q4 | $177M | Sell |
6,078,842
-625,027
| -9% | -$18.2M | 2.18% | 15 |
|
|
2013
Q3 | $183M | Sell |
6,703,869
-117,478
| -2% | -$3.2M | 2.35% | 12 |
|
|
2013
Q2 | $181M | Buy |
+6,821,347
| New | +$188M | 2.27% | 13 |
|
Other funds holding PFE
VCM
VPM
Brandes Investment Partners's PFE Position: Q1 2026 in Review
Brandes Investment Partners increased its Pfizer (PFE) stake by 5.5% in Q1 2026, buying an estimated $12.7M and bringing the position to 9,107,225 shares worth $256M. The position accounts for 1.81% of the portfolio, ranked #11.
Brandes Investment Partners first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Brandes Investment Partners held 9,107,225 shares of Pfizer worth $256M as of Q1 2026.
- Brandes Investment Partners bought 478,043 Pfizer shares in Q1 2026, an estimated $12.7M.
- Pfizer made up 1.81% of Brandes Investment Partners's portfolio in Q1 2026, its #11 holding.
- Brandes Investment Partners first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.